Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.

The natural form of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) decreases proliferation and promotes terminal differentiation of cultured human epidermal keratinocytes. The purpose of this study was to find out to what extent the culture conditions determine the sensitivity of keratinocytes to 1,25(OH)2D3 and synthetic vitamin D analogues. Human keratinocytes were grown in microplates. Cell proliferation (MTT-assay) and differentiation (quantity of transglutaminase type I) were measured consecutively in the same monolayer. When vitamin D3 analogues were added to 50-60% confluent keratinocytes grown in serum-free keratinocyte growth medium with 0.09 mM Ca2+, stimulation of the proliferation was either minimal or non-existent, while differentiation was unaffected or slightly inhibited. There was no difference in the sensitivity to 1,25(OH)2D3 and the vitamin D3 analogues. When 1,25(OH)2D3 was added to less confluent keratinocytes (30%) a marked antiproliferative effect was observed. Addition of 3% charcoal stripped foetal calf serum further enhanced the antiproliferative effect of 1,25(OH)2D3, and a difference in the sensitivity of the vitamin D3 analogues was noted. If, finally, the Ca2+ concentration was raised to 0.3 mM, 1,25(OH)2D3 and the vitamin D3 analogues stimulated differentiation. Also, a biphasic effect on proliferation occurred: stimulation at low vitamin D concentrations and inhibition at higher concentrations. Furthermore, keratinocytes became more sensitive to the synthetic vitamin D3 analogues than to 1,25(OH)2D3: KH1060 > EB1089 > GS1500 > or = EB1213 > calcipotriol > 1,25(OH)2D3. For all compounds tested differentiation occurred at concentrations 10 to 30 times lower than for proliferation. These results indicate that the sensitivity to vitamin D3 analogues as well as the direction of the response to vitamin D3 analogues is dependent on the keratinocyte density, the availability of serum and Ca2+ concentrations.

[1]  R. Gniadecki,et al.  Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3: dependence on cell culture conditions. , 1996, The Journal of investigative dermatology.

[2]  R. Gniadecki,et al.  The effects of KH 1060, a potent 20‐epi analogue of the vitamin D3 hormone, on hairless mouse skin in vivo , 1995, The British journal of dermatology.

[3]  K. Miyazono,et al.  A Human Keratinocyte Cell Line Produces Two Autocrine Growth Inhibitors, Transforming Growth Factor-β and Insulin-like Growth Factor Binding Protein-6, in a Calcium- and Cell Density-dependent Manner (*) , 1995, The Journal of Biological Chemistry.

[4]  A. Norman,et al.  Distinct Conformational Changes Induced by 20-epi Analogues of 1,25-Dihydroxyvitamin D Are Associated with Enhanced Activation of the Vitamin D Receptor (*) , 1995, The Journal of Biological Chemistry.

[5]  W. Bollag,et al.  Biphasic effect of 1,25‐dihydroxyvitamin D3 on primary mouse epidermal keratinocyte proliferation , 1995, Journal of cellular physiology.

[6]  D. Baran,et al.  1α,25‐dihydroxyvitamin D3 rapidly alters phospholipid metabolism in the nuclea envelope of osteoblasts , 1995, Journal of cellular biochemistry.

[7]  H. Koeffler,et al.  Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. , 1995, Leukemia research.

[8]  K. Persons,et al.  Increased PKC activity in cultured human keratinocytes and fibroblasts after treatment with 1α,25‐dihydroxyvitamin D3 , 1995 .

[9]  J. Saurat,et al.  The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  Rajiv Ranjan Kumar,et al.  Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. , 1994, Endocrinology.

[11]  C. Harmon,et al.  Biphasic effect of 1,25-dihydroxyvitamin D3 on human hair follicle growth and hair fiber production in whole-organ cultures. , 1994, The Journal of investigative dermatology.

[12]  D. Bikle,et al.  1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium. , 1994, The Journal of biological chemistry.

[13]  D. Bikle,et al.  Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. , 1993, The Journal of investigative dermatology.

[14]  L. Binderup,et al.  EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  O. Clausen,et al.  1,25‐dihydroxyvitamin D3 and the vitamin D analogue KH1060 induce hyperproliferation in normal mouse epidermis , 1993, Experimental dermatology.

[16]  P. Kerkhof,et al.  Topical treatment of psoriatic plaques with 1,25‐dihydroxyvitamin D3: a cell biological study , 1993, The British journal of dermatology.

[17]  R. Coombes,et al.  EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. , 1992, Biochemical pharmacology.

[18]  M. Katz,et al.  1,25‐dihydroxy‐vitamin‐D3 enhances antiproliferative effect and transcription of TGF‐β1 on human keratinocytes in culture , 1992, Journal of cellular physiology.

[19]  D. Feldman,et al.  Stimulation of 1,25‐dihydroxyvitamin D3 receptor gene expression in cultured cells by serum and growth factors , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  L. Binderup,et al.  20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. , 1991, Biochemical pharmacology.

[21]  D. Hoop,et al.  Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris , 1991, The Lancet.

[22]  K. Matsumoto,et al.  Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. , 1990, Biochemical and biophysical research communications.

[23]  M. Haussler,et al.  Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues , 1988 .

[24]  H. Tagami,et al.  Topically active vitamin D3 analogue, 1α,24‐dihydroxy‐cholecalciferol, has an anti‐proliferative effect on the epidermis of guinea pig skin , 1987, The British journal of dermatology.

[25]  N. Walworth,et al.  Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions , 1986 .

[26]  R. Rice,et al.  Keratinocyte-specific transglutaminase of cultured human epidermal cells: Relation to cross-linked envelope formation and terminal differentiation , 1985, Cell.

[27]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[28]  T. Kuroki,et al.  Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3 , 1983 .

[29]  M. Holick,et al.  The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. , 1995, The Journal of investigative dermatology.

[30]  S. de Vos,et al.  Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. , 1995, Leukemia research.

[31]  M. Holick,et al.  An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells , 1993 .

[32]  B. Shroot,et al.  Determination of retinoid activity by an enzyme-linked immunosorbent assay. , 1991, Analytical biochemistry.